(NASDAQ: GEVO) Gevo's forecast annual revenue growth rate of 7.05% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 5.17%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.84%.
Gevo's revenue in 2026 is $174,419,000.On average, 8 Wall Street analysts forecast GEVO's revenue for 2026 to be $45,715,081,699, with the lowest GEVO revenue forecast at $40,708,110,662, and the highest GEVO revenue forecast at $50,094,051,508. On average, 7 Wall Street analysts forecast GEVO's revenue for 2027 to be $49,909,058,898, with the lowest GEVO revenue forecast at $43,843,248,579, and the highest GEVO revenue forecast at $55,086,417,866.
In 2028, GEVO is forecast to generate $51,671,356,920 in revenue, with the lowest revenue forecast at $44,337,373,577 and the highest revenue forecast at $57,187,057,635.